StockWatch
·

Moneyboxx Finance Ltd Q2 FY27 Results

MONEYBOXXQ2 FY27 Results
Filing
Result:Poor· Market: Flat#One-off gain#Base effect

Outlook: Cautiously Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue60.9617.2%10.8%
Total Income61.0217.1%10.8%
Expenditure60.0115.7%9.6%
PBT1.01317.9%223.6%
Net Profit0.91337.8%225.4%
OPM40.78%4.96pp2.15pp
NPM1.49%1.09pp0.98pp
EPS0.16433.3%77.8%
View full financials

Headline PAT growth is entirely manufactured by a ₹16.67 Cr derecognition/gain-on-sale line; stripped of that, the core lending book's adjusted pre-tax loss widened roughly 34x YoY (₹0.42 Cr to ₹15.66 Cr), with pristine reported GNPA/NNPA reflecting stressed-loan sales to an ARC rather than genuine asset-quality improvement.

MONEYBOXX · Q2 FY27 · THE VERDICT

Disbursements accelerating, margins under pressure

Revenue grew 10.8% YoY and PAT surged 225%, but reported Q2 PAT of just ₹0.9 Cr masks a ₹11.5+ Crore provisioning charge in H1. The company's margin recovery rests on unproven partnership scaling and unexplained reserve normalization.

13 Nov 2026 · 6 min read
Reported PAT

₹0.9 Cr

+225% YoY, but…

Pre-prov PAT (H1)

₹12.41 Cr

implies ₹11.5+ Cr reserve charge

Net margin

1.5%

vs 40.8% operating margin

AUM

₹802 Cr

73% secured, on track for ₹1,100–1,200 Cr by Mar 27

On the headline, Moneyboxx's Q2 looks punchy: revenue up 10.8% YoY, PAT up 225%. But beneath lies a puzzle that frames the entire quarter. Pre-provisioning profit in the first half was ₹12.41 Cr; reported PAT just ₹0.9 Cr. That ₹11.5+ Crore gap is management's reserve bill — and they never explained why, or when it normalizes.

The company is executing hard on growth: disbursements have doubled in five months (₹24.5 Cr in Aug → ₹50 Cr in Oct), with ₹100 Cr/month targeted by November. That's real momentum. Four new lending channels — Akshayakalpa (dairy), Bachatt and Loom (digital), and rooftop solar — are live and generating early traction (₹2–17 Cr AUM each). But the path to profitability recovery remains foggy, and the street has taken note: the stock is down 54% from its all-time high, trading below all key moving averages.

The margin mystery

H1 FY27, ₹ Cr
-14.38-4.495.3915.2812.41Pre-prov PAT-11.51Less: Provisions0.9Reported PAT
The ₹11.51 Crore provision charge represents 93% of pre-provisioning profit. Management disclosed no rationale, driver, or normalization timeline.

A heavy provisioning charge is not inherently a red flag — conservative accounting can be prudent. But transparency matters. The company's operating metrics are actually strengthening: 90+ PAR fell sharply to 2.56% (from 6.25% in March), collection efficiency stands at 92.5%, and NPA is negligible at 0.01%. So why the reserve bump? Management's silence on this is the quarter's unresolved tension.

We are sitting at a reasonable leverage ratio, which means that funding for next 2, 3 quarters doesn't seem to be a challenge because right now, AUM is ₹800 crores.

What changed on this call

Management's claims vs. what the numbers say

Strong disbursement momentum; ₹50 Cr monthly in Oct.

Confirmed: ₹24.5 Cr (Aug) → ₹32.4 Cr (Sep) → ₹50 Cr (Oct). Math checks for ₹100 Cr target by Nov.

Supported

Secured portfolio increased, improving asset quality.

Secured 73% (Sep 26) vs prior 75% target (slight slip); 90+ PAR 2.56% vs 6.25% (Mar 26). Collections strong at 92.5%.

Partially supported; secured % regressed

AUM on track for ₹1,100–1,200 Cr by March 2027.

AUM ₹802 Cr (Sep 26); requires 38–50% growth in 6 months. Disbursement ramp (₹50 → ₹100 Cr/month) aligns mechanically.

Supported (model-wise)

Partnership-led lending (dairy, digital) will add ₹30–50+ Cr/month.

Akshayakalpa (dairy) ₹2 Cr Sep, targeting ₹25–30 Cr/month by Jan 2027; digital (Bachatt, Loom) ₹2 Cr combined, targeting ₹20–30 Cr by Jan. Early-stage, unproven at scale.

Overstated (optimistic on timing)

Strong funding position; 36 lenders, 12 leading banks, ₹170 Cr liquidity.

Liquidity confirmed; NCD issuance ₹110 Cr (Q2); funding cost up 25–30 bps. Concentration in 12 banks; scaling to ₹1,100+ Cr AUM may strain diversity.

Supported (near-term; risk rising)

Three structural shifts

1. Partnership-led growth is now the story. Secured direct lending (the core MSME business) is still 73% of AUM, but the new engines — dairy (Akshayakalpa with FLDG first-loss guarantee), digital (Bachatt, Loom), and rooftop solar — are meant to accelerate AUM to ₹1,100–1,200 Cr by March 2027. Management is confident; the market is not. These channels are early-stage, sourced through partners, and untested in a macro slowdown.

2. Secured portfolio target has regressed. Prior guidance was 80% secured by March 2027; current standing is 73%. The shift reflects deliberate strategy (unsecured and partnerships yield higher spreads) but introduces concentration risk into new, high-growth segments. If macro deteriorates or partner execution stumbles, PAR could spike.

3. Operating leverage gains are being reinvested, not harvested. TAT halved via the Moneyboxx ONE LOS (from ~10 days to 6.5–7 days), Cattle AI is reducing manual screening by 30–40%, and opex/AUM is 14.3% (target <10% by 2028). All these savings are plowed into branch expansion and partnership ramp. The margin recovery the company needs is still 2–3 quarters away, if it happens at all.

Risk ledger

Ranked by how much they should concern a holder

Profitability path opaque; heavy provisioning drag (₹11.5 Cr H1) unexplained.

High

Pre-prov PAT ₹12.41 Cr H1 vs reported ₹0.9 Cr. Lack of management disclosure on reserve driver or normalization timeline erodes confidence in margin recovery.

Partnership execution risk; dairy, digital, solar channels unproven at scale.

High

Akshayakalpa targeting ₹25–30 Cr/month by Jan 2027 (from ₹2 Cr Sep); Bachatt/Loom aiming ₹20–30 Cr/month. Customer acquisition, churn, and credit quality are unvalidated.

Secured portfolio declined; unsecured/partnership mix rising.

Medium

Secured 73% vs 75% prior target. New channels have higher yields but also higher risk. If macro deteriorates, PAR could spike and unwind gains in collection efficiency.

Funding cost inflation and lender concentration.

Medium

Borrowing rates up 25–30 bps; 36 lenders with 12 leading banks. Scaling to ₹1,100–1,200 Cr AUM may strain funding diversity; capital market access still limited.

Asset quality deterioration in macro slowdown.

Medium

Current PAR/NPA metrics are strong (90+ PAR 2.56%, NPA 0.01%). But rapid growth into unsecured/partnership lending with small-ticket MSME (avg ₹6.7 lakh) could see collections pressure if external shocks hit borrower cash flows.

How the street is positioned

Price & drawdown: The stock trades at ₹41.5, down 54% from its all-time high of ₹91.5. It is trading below its 20-day (₹47.68), 50-day (₹52.57), and 200-day (₹61.9) moving averages — a steep drawdown on a multi-timeframe basis. The 52-week range is ₹35.85–₹91.5; the stock is off the lows by only 15.76%, suggesting weak conviction. RSI is 38.9 (neutral), and volume is declining. The market's verdict on the quarter is skeptical: growth alone is not enough without margin visibility.

Institutional flow: FII ownership is 0.00% (Q1 FY27), unchanged from prior quarters. DII has been near 0% historically. Promoter ownership stands steady at 46.79%. The absence of institutional buying despite growth acceleration underscores concern over profitability and execution risk. No bulk trades are reported, but the lack of institutional momentum on a 54% drawdown is itself a signal: sophisticated money sees risk, not a bargain.

The debate

What to watch next

Next quarter's verdict
  • 1 · Monthly disbursement hit ₹100 Cr by Nov 2026?

    October was ₹50 Cr. November's run-rate (to be reported in Q3 earnings, likely Jan 2027) is the first hard check on partnership ramp credibility. If it stalls at ₹60–70 Cr, March 2027 AUM target is at risk.

  • 2 · Q3 pre-prov PAT and reserve rate guidance.

    The ₹11.5 Cr provisioning charge in H1 is the elephant in the room. Does management disclose the reserve driver and normalize the rate, or does it remain opaque? This determines whether profitability recovery is credible or stalled.

  • 3 · Secured portfolio stabilization or further decline?

    Secured is now 73% vs 75% prior. If it drops below 70% by March 2027, the strategy shift toward unsecured/partnerships is confirmed, raising refinance risk.

Valuation & near-term

Moneyboxx is not yet a profitable growth story — it's a growth story seeking profitability. The 54% drawdown from ATH is overdone if the company executes on disbursement targets and stabilizes margins above 5% by March 2027. It is justified if partnerships fail or reserve pressure persists. At ₹41.5, the stock is pricing in material execution risk. The question is whether that risk premium (vs. peers' forward earnings multiples on proven profitability) is warranted.

Moneyboxx's Q2 confirms strong execution on disbursement acceleration and credit quality improvement. But it also surfaces a profitability puzzle that management has not addressed. The ₹11.5+ Crore provisioning charge in H1 — and its trajectory in Q3 and Q4 — is the single number that determines whether the march to ₹1,100+ Cr AUM yields margin recovery or just asset-heavy stagnation.

The street is right to be skeptical until that gap closes. Hold for now; upgrade only if Q3 brings clarity on reserves and partnership execution validates the new growth drivers. The number to track: pre-prov PAT in Q3 FY27, and management's guidance on reserve normalization.

Informational and educational content only. Not investment advice.